Ipilimumab vs Warfarin
Ipilimumab vs Warfarin: Overview
This comparison examines the pharmacological differences between Ipilimumab and Warfarin.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Warfarin: Inhibits vitamin K epoxide reductase complex.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Warfarin β 20-60 hours.
Chemical Properties
Molecular Formula: Warfarin β C19H16O4.
Molecular Weight: Warfarin β 308.3280 g/mol.
Type: Ipilimumab β Antibody; Warfarin β Small molecule.